<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">

Hybrid clinical trials with 20/20 Onsite

Accelerate enrollment, expand reach, and create a frictionless patient experience

With more than 80% of US clinical trials failing to meet their patient enrollment timelines and with an average of 30% of patients dropping out, mobile vision clinics are a game changer.

case_study

Applied Genetics Technology Company (AGTC) partners with 20/20 for their nationwide ophthalmic phase 1 and 2 clinical trials

press_release

Observational Study Confirms Eye Exams in Mobile Settings Have the Same Results as In-Office Exams

white_paper

Keeping Your Trials on Track: How Mobile Vision Clinics Are Making an Impact on Pre-screening, Screening and Retention

TAKE A TOUR

Schedule a tour of one of our state-of-the-art mobile vision clinics

Clinical Trials and Research

Support for ocular assessments or other study-specific eye procedures as part of a research protocol

Late Phase or Post-marketing

Support for safety or surveillance eye exams for patients outside of a clinical protocol

Meet 20/20 Onsite's Industry and Scientific Advisory Board

The Industry and Scientific Advisory Board (IASAB) meets quarterly to help identify patient needs, product opportunities, and market challenges associated with the provision of vision-related assessments for clinical trials and safety surveillance.

Adam-Ramsey-Headshot
Adam Ramsey, OD

Owner Socialite Vision

Beth-Marsh-Headshot
Beth Marsh

Vice President of North America Sales and Marketing, Ophthalmology Apellis Pharmaceuticals

Jason-Menzo-Headshot
Jason Menzo

Chief Operating Officer Foundation Fighting Blindness

Headshot-Jeanne
Jeanne Hecht, Chair

Founder and CEO JTH Consulting, LLC

Jeffrey-S.-Heier-Headshot
Jeffrey S. Heier, MD

Director of the Vitreoretinal Service and Director of Retina Research Ophthalmic Consultants of Boston (OCB)

Peter Kaiser Headshot-1
Peter K. Kaiser, MD

Chaney Family Endowed Chair in Ophthalmology Research and Professor of Ophthalmology Cleveland Clinic Lerner College of Medicine

Rajat-Agrawal-Headshot
Rajat Agrawal, MD, MS

CEO and President Retina Global

Medical-Solution-1

Click below to read more about each board member's commitment to research or submit a question to be asked during our next quarterly meeting.

SIGN UP FOR UPDATES

Eyes on Research
A monthly newsletter dedicated to reasearch and insights on patient-first treatments